Nicholas Saraceno is editor at Pharmaceutical Commerce.
FDA Grants Approval to Kedrion to Produce PLGD-1 Therapeutic at Bolognana Plant
FDA's approval will allow Kedrion to manufacture Ryplazim (plasminogen, human-tvmh), the only FDA-approved therapy for treating PLGD-1, at facility in Bolognana, Italy.
Fujifilm's Cell Therapy Facility Expansion Completed
The Thousand Oaks, Calif., cell therapy manufacturing facility now houses new production suites, updated development labs, and more after expansion.
Pii Boosts Prefilled Syringe Capabilities with $3.6 Million Investment
The $3.6 million investment will allow the CDMO to boost its advanced labeling, automated visual inspection, and fill/finish capabilities.